20/20 GLOBAL, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

ITEM 7.01-REGULATION FD DISCLOSURE

On January 20, 2021, a press release was issued respecting 20/20 Global, Inc., and its wholly owned subsidiary, Mycotopia Therapies Inc., a copy of which is attached as Exhibit 99.01.

                  ITEM 9.01-FINANCIAL STATEMENTS AND EXHIBITS

The following is filed as an exhibit to this report:

         Exhibit
         Number                 Title of Document                 Location

         Item 99    Miscellaneous
          99.01       Press Release dated January 20, 2021.     This filing.


_______________

*All exhibits are numbered with the number preceding the decimal indicating the applicable SEC reference number in Item 601 and the number following the decimal indicating the sequence of the particular document.

© Edgar Online, source Glimpses